Skip to main content

FDA recall, , High risk

Baxter 0.9% Sodium Chloride Injection

0.9% Sodium Chloride Injection contains fiberglass particulate matter that may cause serious health consequences.

What happened

Baxter Healthcare Corporation, based in Deerfield, Illinois, is voluntarily recalling 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case, due to the potential presence of particulate matter identified as fiberglass in the solution. The recall began on August 17, 2026, and was announced by the company on August 25, 2026, affecting 145,464 500mL bags distributed in the USA.

The product was added to the FDA's Enforcement Report on August 31, 2026, and included in the FDA's weekly enforcement report on September 9, 2026. The FDA classified the recall on September 15, 2026.

What to do

If a code on your package is listed below:

  1. Immediately discontinue use of and return all affected units in accordance with your facility’s process.
  2. Consumers with questions regarding this recall can contact Baxter Healthcare Center for Service at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.
  3. Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

Is yours affected?

Match the lot code, best-by or expiration date and NDC listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. 2B1323Q

    NDC
    • 0338-0049-03
    Lot code
    • Y495523
    • Y495523A
    Best-by or expiration date
    31-Oct-2027

Recall details

Company began the recall
Sold in

Natonwide in the USA

Company
Baxter Healthcare CorporationDeerfield, Illinois
Risk

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
99678
Recall number
D-0849-2026
Quantity recalled
145,464 500mL bags

All recalls from Baxter Healthcare Corporation

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Announced by the company

  3. Listed on Recall Canary

  4. Added to FDA's Enforcement Report

  5. In FDA's weekly enforcement report

  6. Classified by FDA

  7. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 7, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)